General Practitioner Dr Kerry Hancock, uses a real-world patient case and supporting evidence to outline how a single-inhaler triple therapy can improve symptom control of COPD.
In this Quick Case:
General Practitioner Dr Kerry Hancock, uses a real-world patient case and supporting evidence to outline how Trimbow 100 (beclometasone/formoterol/glycopyrronium) can improve symptom control and reduce exacerbation risk in people with COPD (5 mins).
This video was produced with funding from Chiesi Australia
Trimbow 100/6/10 and Trimbow 200/6/10 are indicated for maintenance treatment in adults with asthma not adequately controlled with a maintenance
combination of medium dose or high dose ICS/LABA respectively and who experienced ≥1 exacerbation(s) in the previous year.
Trimbow 100/6/10 is indicated in adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/ LAMA.
Please review Product Information before prescribing. The Product Information can be accessed here
PBS Information: Trimbow. Authority required (STREAMLINED). Severe asthma. Chronic Obstructive Pulmonary Disease (100/6/10 mcg presentation only). Criteria Apply. Refer to PBS for full information.
